Author(s):
Prerna Tiwari, Pratibha Tiwari, Pratixa Patel
Email(s):
prerna15122002@gmail.com
DOI:
10.52711/2231-5713.2025.00029 
Address:
Prerna Tiwari1*, Pratibha Tiwari, Pratixa Patel
1ROFEL Shri G.M. Bilakhia College of Pharmacy, Vapi, Gujarat, 396191, India.
2ROFEL Shri G.M. Bilakhia College of Pharmacy, Vapi, Gujarat, 396191, India.
3Department of Pharmacology, ROFEL Shri G.M. Bilakhia College of Pharmacy, Vapi, Gujarat, 396191, India.
*Corresponding Author
Published In:
Volume - 15,
Issue - 2,
Year - 2025
ABSTRACT:
Antimicrobial resistance (AMR) is emerging as one of the most significant threats to global public health, with the potential to reverse the medical advances achieved over the past century. Since Alexander Fleming's discovery of penicillin in 1928, antibiotics have been indispensable in treating bacterial infections, enabling safe surgical procedures, and extending life expectancy. However, the efficacy of these life-saving drugs is rapidly diminishing due to the widespread misuse and overuse of antibiotics in both human medicine and agriculture. AMR occurs when bacteria evolve mechanisms to withstand the effects of antibiotics, rendering standard treatments ineffective. The primary mechanisms of resistance include the reduction of drug uptake, modification of drug targets, enzymatic inactivation of drugs, and the active efflux of antibiotics out of bacterial cells. These resistant strains can spread through human contact, environmental reservoirs, and the food chain, exacerbated by the use of antibiotics in animal husbandry. The consequences of AMR are dire. Infections that were once easily treatable are becoming increasingly difficult and expensive to manage, leading to higher rates of morbidity and mortality. The financial burden on healthcare systems is substantial, with prolonged hospital stays, the need for more expensive drugs, and the requirement for more intensive care. To address this growing crisis, a multifaceted approach is essential. Stricter regulations on the use of antibiotics, both in healthcare settings and in agriculture, are critical to curbing the spread of resistance. Enhancing access to vaccines and promoting appropriate use of existing antibiotics can help prevent infections and reduce the need for antibiotic use. Additionally, international cooperation is crucial for monitoring and responding to AMR on a global scale. Investing in research and development of new antibiotics and alternative therapies is also imperative. Public awareness campaigns aimed at educating both healthcare professionals and the general public about the dangers of antibiotic misuse are essential for changing behaviour. Without these immediate and coordinated efforts, AMR could lead to a future where routine surgeries, chemotherapy, and even minor infections become life-threatening, effectively turning back the clock on modern medicine.
Cite this article:
Prerna Tiwari, Pratibha Tiwari, Pratixa Patel. Unseen Threat: The Growing Problem of Antimicrobial Resistance. Asian Journal of Pharmacy and Technology. 2025; 15(2):181-8. doi: 10.52711/2231-5713.2025.00029
Cite(Electronic):
Prerna Tiwari, Pratibha Tiwari, Pratixa Patel. Unseen Threat: The Growing Problem of Antimicrobial Resistance. Asian Journal of Pharmacy and Technology. 2025; 15(2):181-8. doi: 10.52711/2231-5713.2025.00029 Available on: https://ajptonline.com/AbstractView.aspx?PID=2025-15-2-13
REFERENCE:
1. Tan SY, Tatsumura Y. Alexander Fleming (1881-1955): Discoverer of penicillin. Singapore Med J. 2015 Jul;56(7):366-7. doi: 10.11622/smedj.2015105. PMID: 26243971; PMCID: PMC4520913.
2. Gould K. Antibiotics: from prehistory to the present day. J Antimicrob Chemother. 2016 Mar;71(3):572-5. doi: 10.1093/jac/dkv484. PMID: 26851273.
3. Prestinaci F, Pezzotti P, Pantosti A. Antimicrobial resistance: a global multifaceted phenomenon. Pathog Glob Health. 2015;109(7):309-18. doi: 10.1179/2047773215Y.0000000030. Epub 2015 Sep 7. PMID: 26343252; PMCID: PMC4768623.
4. World Antimicrobial Awareness Week. 2020. Available online: https://www.who.int/campaigns/world-antibiotic-awarenessweek (accessed on 18 November 2020).
5. Baker SJ, Payne DJ, Rappuoli R, De Gregorio E. Technologies to address antimicrobial resistance. Proc Natl Acad Sci U S A. 2018 Dec 18;115(51):12887-12895. doi: 10.1073/pnas.1717160115. PMID: 30559181; PMCID: PMC6304975.
6. Pelfrene E, Botgros R, Cavaleri M. Antimicrobial multidrug resistance in the era of COVID-19: a forgotten plight? Antimicrob Resist Infect Control. 2021 Jan 29;10(1):21. doi: 10.1186/s13756-021-00893-z. PMID: 33514424; PMCID: PMC7844805.
7. Bhushan P. Gayakwad, Shashikant D. Barhate, Prafull P. Patil, . Mayur S. Jain. Comparative Study of Gatifloxacin and Sparfloxacin as Quinolone Antibiotics: An Overview. Asian J. Pharm. Res. 2018; 8(1): 44-46
8. Safa Mohammed Sadiq, Amtul Kareem, Nuha Rasheed, Abdul Saleem Mohammad. Pharmaceutical Importance of Anti-Microbials. Asian J. Pharm. Tech. 2017; 7(1): 7-10. doi: 10.5958/2231-5713.2017.00002.2
9. Hafsa, Asfa, Nuha Rasheed, Abdul Saleem Mohammad. Pharmaceutical Aids – a Review Study. Asian J. Pharm. Tech. 2016; 7(1): 1-6. doi: 10.5958/2231-5713.2017.00001.0
10. Wajid Ahmad, Jaza Quazi, Reshma Khan, Nadeem Ahmad, Nawed Ansari. A Comprehensive Review on Microspheres. Asian Journal of Pharmacy and Technology. 2022; 12(2):136-0. doi: 10.52711/2231-5713.2022.00023
11. Beedha. Saraswathi, Dr. T. Satyanarayana, K. Mounika, G. Swathi, K. Sravika, M. Mohan Krishna. Formulation and Characterization of Tramadol HCl Transdermal Patch. Asian J. Pharm. Tech. 2018; 8 (1):23-28. doi: 10.5958/2231-5713.2018.00004.1
12. K. V. M. Krishna, V. Jagannadha Patro. Articulation and Evaluation of Extended-Release Beads using a Sulfasalazine Drug. Asian Journal of Pharmacy and Technology. 2023; 13(1):25-8. doi: 10.52711/2231-5713.2023.00005
13. Kanchan R. Pagar, Sarika V. Khandbahale. A Review on Novel Drug Delivery System: A Recent Trend. Asian J. Pharm. Tech. 2019; 9(2):135-140. doi: 10.5958/2231-5713.2019.00023.0
14. Sushil D. Patil, Bhavini D. Chande, Kirti M. Budukhale, Radhika V. Damare, Nilam Kale, Shivangi S. Pathak. Evaluation Ixora coccinea Formulation for antibacterial and antioxidant activity. Asian J. Pharm. Tech. 2018; 8 (2):88-91. doi: 10.5958/2231-5713.2018.00014.4
15. Nidhi Rao, Sandhya Mittal, Sudhanshu, Ekta Menghani. Assessment of Phytochemical Screening, Antioxidant and Antibacterial Potential of the Methanolic Extract of Ricinus communis l. Asian J. Pharm. Tech. 3(1): Jan.-Mar. 2013; Page 20-25.
16. Marwa Fady Abozed, Hemat K. Abd El Latif, Fathy M. Serry, Lotfi M. El Sayed. Activity of commonly used intravenous nutrient and bisolvon in neonatal intensive care units against biofilm cells and their synergetic effect with antibiotics. Asian J. Pharm. Tech. 3(2): April-June. 2013; Page 81-90.
17. Mr. Mayur S. Jain, Dr. Shashikant D. Barhate. Tigecycline is the First Clinically-Available Drug in a new class of Antibiotics called the Glycylcyclines: A Review. Asian J. Pharm. Tech. 2020; 10(1):48-50. doi: 10.5958/2231-5713.2020.00010.0
18. Giurazza R, Mazza MC, Andini R, Sansone P, Pace MC, Durante-Mangoni E. Emerging Treatment Options for Multi-Drug-Resistant Bacterial Infections. Life (Basel). 2021;11(6):519. doi:10.3390/life11060519. PMCID: PMC8229628; PMID: 34204961.
19. Zarzosa SG, Cuesta CS, Plaza SG, Lucas JH, Sanchez RdP. Compassionate Use of Cefiderocol to Treat Tissue Infection Caused by MDR-Pseudomonas Aeruginosa in a Critically Ill Patient. Chilean J Anesth. 2022;51(2):213-216. doi:10.25237/revchilanestv5109021126.
20. Xu C, Wei X, Jin Y, Bai F, Cheng Z, Chen S, Pan X, Wu W. Development of Resistance to Eravacycline by Klebsiella pneumoniae and Collateral Sensitivity-Guided Design of Combination Therapies. Microbiol Spectr. 2022;10. doi:10.1128/spectrum.01390-22.